BioSpace News Archive

Business

ReForm Biologics Inc. Announces Appointments of Kevin Kavanaugh, CPA, to Chief Financial Officer and Robert Mahoney, PhD, to Chief Scientific Officer

ReForm Biologics Inc. today announced that Robert Mahoney, PhD, has been promoted to Chief Scientific Officer (CSO) and that Kevin Kavanaugh, CPA, has been promoted to Chief Financial Officer.

October 13, 2021
·
2 min read
Drug Development

NeoImmuneTech Announces First Patient Dosed in Phase 1b Study of NT-I7 (efineptakin alfa) and Kymriah® (tisagenlecleucel) in Relapsed/Refractory Large B-Cell Lymphoma

NeoImmuneTech, Inc. today announced that the first patient has been dosed in a Phase 1b study of its lead drug candidate, NT-I7 (efineptakin alfa), a novel long-acting human interleukin-7 (IL-7), following CAR-T cell therapy tisagenlecleucel (Kymriah®) in patients with relapsed/refractory (r/r) Large B-Cell Lymphoma (LBCL).

October 13, 2021
·
4 min read
Business

Cohealo Appoints Veteran Healthcare Technology Executive as Chief Operating Officer

Cohealo, a platform for health systems to track and share medical equipment, today announced that Tom Cady will join Cohealo’s leadership team as chief operating officer.

October 13, 2021
·
2 min read
Pharm Country

Bristol Myers Squibb Announces Up to Five Years of Data from Long-Term DAYBREAK Study Reinforcing Efficacy and Safety Profile of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Sclerosis

Bristol Myers Squibb Announces Up to Five Years of Data from Long-Term DAYBREAK Study Reinforcing Efficacy and Safety Profile of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Sclerosis

October 13, 2021
·
18 min read
Genetown

New Real-World MAVENCLAD® Data Show Sustained Effectiveness and Benefit on Quality-of-Life Measures in RMS Patients

New Real-World MAVENCLAD ® Data Show Sustained Effectiveness and Benefit on Quality-of-Life Measures in RMS Patients

October 13, 2021
·
14 min read
Business

LianBio Appoints Jesse Wu to Board of Directors

LianBio today announced the appointment of Jesse Wu to the company’s Board of Directors.

October 13, 2021
·
2 min read
Genetown

Axial Therapeutics Raises $37.25 Million in Series C Financing to Advance its Pipeline of Gut-Targeted Small Molecule Drugs for Neurological Diseases and Disorders

Axial Therapeutics today announced the completion of a $37.25 million Series C financing.

October 13, 2021
·
5 min read
Business

Taysha Gene Therapies Announces Sponsored Genetic Testing for Giant Axonal Neuropathy (GAN) in Partnership with GeneDx as well as a Collaboration with Hereditary Neuropathy Foundation and Charcot-Marie-Tooth Association Centers of Excellence

Taysha Gene Therapies, Inc. today announced sponsored genetic testing for giant axonal neuropathy (GAN) in partnership with GeneDx, Inc.

October 13, 2021
·
9 min read
Subtle Medical Receives Health Canada Approval for Increased Imaging Efficiency

Subtle Medical, a healthcare technology company improving the quality and efficiency of medical imaging, announced today Health Canada/Santé Canada approval for their suite of AI-powered image enhancement solutions.

October 13, 2021
·
2 min read
Business

Foundation Medicine Appoints Dymeka Harrison as Chief Commercial Officer

Foundation Medicine, Inc. today announced the appointment of Dymeka Harrison, MBA, as its Chief Commercial Officer.

October 13, 2021
·
3 min read